Insulin Delivery Systems Market Trends, Size, Analysis and Forecast to 2020

Technavio Announces the Publication of its Research Report Global Insulin Delivery Systems Market 2016-2020

Technavio recognizes the following companies as the key players in the global insulin delivery systems market: Novo Nordisk, Sanofi, BD, Eli Lilly, and Medtronic.

Other Prominent Vendors in the market are: Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, InsuJet¸ Insulet, MannKind, Owen Mumford, Roche¸ SHL, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma¸ and Ypsomed.

Browse full report with TOC@ https://marketreportscenter.com/reports/374195/global-insulin-delivery-systems-market-2016-2020

Commenting on the report, an analyst from Technavios team said: One of the key trends for market growth will be the presence of strategic alliances leading to innovative insulin delivery systems. In November 2015, Debiotech, the ARTORG Center for Biomedical Engineering Research of the University of Bern, and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital collaborated to develop a novel generation artificial pancreas for the personalized delivery of insulin with the accuracy of an MEMS based pump. The ambition is to create a substantial change in the treatment of diabetes and in the market for the artificial pancreas.”

According to the report, one of the key drivers for market growth will be to focus on self-management of diabetes. The adoption of insulin delivery systems for type-1 diabetes management has increased in recent years. The adoption rate is increasing due to factors such as awareness, health consciousness, and a marginal improvement of healthcare policies allowing some reimbursement for insulin delivery devices. The devices used in hospitals and specialty clinics are now being used in home care treatment by patients. This trend is seen largely because it helps save the visiting costs and fees of hospitals and clinics, and saves waiting time. In recent times, normal insulin...